Date | Name | Shares | Transaction | Value |
May 20, 2025
| Yvette K. Schultz See Remarks |
306,819
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $39.86 per share |
12,229,805.34
|
Apr 15, 2025
| Benjamin A. Hardesty Director |
175,423
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 15, 2025
| Vicky Sutil Director |
96,512
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 15, 2025
| Thomas B. Tyree Director |
96,512
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 15, 2025
| Jeffrey S. Munoz Director |
2,658
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 15, 2025
| W. Howard Keenan Director |
364,992
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 15, 2025
| Jacqueline C. Mutschler Director |
62,045
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 15, 2025
| Robert J. Clark Director |
76,589
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 15, 2025
| Brenda R. Schroer Director |
30,715
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 14, 2025
| Sheri L. Pearce See Remarks |
81,887
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $35.6 per share |
2,915,177.20
|
Mar 14, 2025
| Benjamin A. Hardesty Director |
173,740
| Bona fide gift |
0.00
|
Mar 14, 2025
| Benjamin A. Hardesty Director |
500
| Bona fide gift |
0.00
|
Mar 11, 2025
| Paul M. Rady See Remarks; Director |
74,008
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2025
| Sheri L. Pearce See Remarks |
91,717
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $33.64 per share |
3,085,359.88
|
Mar 11, 2025
| Paul M. Rady See Remarks; Director |
11,833,254
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $33.64 per share |
398,070,664.56
|
Mar 11, 2025
| Paul M. Rady See Remarks; Director |
11,888,770
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2025
| Michael N. Kennedy See Remarks |
1,179,277
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2025
| Michael N. Kennedy See Remarks |
1,155,405
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $33.64 per share |
38,867,824.20
|
Mar 11, 2025
| Michael N. Kennedy See Remarks |
31,823
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2025
| Yvette K. Schultz See Remarks |
19,427
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|